Zhang, J., Leventakos, K., Leal, T. A., Pennell, N. A., Barve, M., Paulson, S., . . . Spira, A. (2023). Additional Practice-informing Adverse Event Patterns and Management in the KRYSTAL-1 Phase 2 Study of Adagrasib (MRTX849) in Patients With KRASG12C-mutated Non--Small Cell Lung Cancer...Academy of Oncology Nurse & Patient Navigators (AONN+) 14th Annual Navigation & Survivorship Conference, November 15–19, 2023, San Antonio, Texas. Journal of Oncology Navigation & Survivorship, 14(11), 350-351.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Zhang, Jun, et al. "Additional Practice-informing Adverse Event Patterns and Management in the KRYSTAL-1 Phase 2 Study of Adagrasib (MRTX849) in Patients With KRASG12C-mutated Non--Small Cell Lung Cancer...Academy of Oncology Nurse & Patient Navigators (AONN+) 14th Annual Navigation & Survivorship Conference, November 15–19, 2023, San Antonio, Texas."
Journal of Oncology Navigation & Survivorship 14, no. 11 (2023): 350-351.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Zhang, Jun, et al. "Additional Practice-informing Adverse Event Patterns and Management in the KRYSTAL-1 Phase 2 Study of Adagrasib (MRTX849) in Patients With KRASG12C-mutated Non--Small Cell Lung Cancer...Academy of Oncology Nurse & Patient Navigators (AONN+) 14th Annual Navigation & Survivorship Conference, November 15–19, 2023, San Antonio, Texas."
Journal of Oncology Navigation & Survivorship, vol. 14, no. 11, 2023, pp. 350-351.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.